T-Wave Alternans in Patients With Suspected Acute Coronary Syndrome
TWA
T-Wave Alternans in Patients Acute Coronary Syndrome
1 other identifier
observational
252
1 country
1
Brief Summary
The purpose of this study is to measure T-Wave Alternans (TWA) in patients with acute coronary syndrome. Researchers are blinded to clinical TWA measurements. The investigators will then try to determine if T-Wave alternans correlates with clinical outcome of patients with Acute Coronary Syndrome. During routine care of the patient, the T Wave Alternans is measured.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 3, 2010
CompletedFirst Posted
Study publicly available on registry
June 4, 2010
CompletedStudy Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedMay 26, 2014
May 1, 2014
3.4 years
June 3, 2010
May 22, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
correlation of T-Wave Alternans with Acute myocardial Ischemia
We hope to correlate the Twave Alternans with Acute Myocardial Ischemia. Most importantly we are trying to create a sensitive measure of acute myocardial Ischemia or a rule out study.
6 month
Study Arms (1)
Chest Pain
Acute Myocardial ischemia
Interventions
Eligibility Criteria
18-100 Pt presenting with Chest Pain
You may qualify if:
- Adults with Acute Chest Pain
You may not qualify if:
- Patients with underlying myoclonic tremors making measurement artifact unreliable
- Less than 18 years of age
- Skin disorders that do not allow the Cardiac Monitor Leads to adhere to the skin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Loma Linda University
Loma Linda, California, 92562, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2010
First Posted
June 4, 2010
Study Start
July 1, 2010
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
May 26, 2014
Record last verified: 2014-05